Skip to Content
  • Previous Rank107
  • Revenues ($M)$30,737
  • Revenue Percent Change15.9%
  • Profits ($M)$165.5
  • Profits Percent Change-92.2%
  • Assets ($M)$11,277
  • Employees70,580
  • Market Value — as of March 31, 2017 ($M)$4,473

The proposed $9.4 billion merger between Rite Aid and Walgreens faces increasing scrutiny from the Federal Trade Commission. Rite Aid CEO John Standley has criticized what he says is a drawn-out regulatory process but has also admitted that the uncertainty around the deal is taking a hit on the pharmacy and drug store chain’s business. In a recent letter to employees, Standley seemed to imply that Rite Aid is mulling how to proceed if the deal falls through.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

John T. Standley
CEO Title
Chairman & Chief Executive Officer
Food & Drug Stores
Food and Drug Stores
HQ Location
Camp Hill, PA
Years on Fortune 500 List23
Figures are for fiscal year ended Feb. 29, 2016.

Rite Aid Rank History

Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$30,73715.9%
Profits ($M)$165.5-92.2%
Assets ($M)$11,277-
Total Stockholder Equity ($M)$581-
Market Value — as of March 31, 2017 ($M)$4,473-

Profit Ratios

Profit as % of Revenues0.5%
Profits as % of Assets1.5%
Profits as % of Stockholder Equity28.5%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)0.16
EPS % Change (from 2015)-92.3%
EPS % Change (5 year annual rate)-
EPS % Change (10 year annual rate)-21.9%

Total Return

Total Return to Investors (2016)5.1%
Total Return to Investors (5 year, annualized)45.6%
Total Return to Investors (10 year, annualized)4.2%